International network for natural sciences – research journal
  • mendeley icon
  • linkedin icon
  • google plus icon
  • twitter icon
  • google scholar icon
  • facebook icon

Prevalence of metabolic syndrome and associated risk factors in the population of southern

By: Basile G. Sognigbé, Nicodème Worou Chabi, Victorien T. Dougnon, Esther Duéguénon, Arnaud N. Kohonou, Véronique B.T. Tinéponanti, Lamine Baba-Moussa

Key Words: Metabolic syndrome, IDF, Prevalence, Risk factors, Southern Benin.

Int. J. Biosci. 15(5), 205-217, November 2019.


Certification: ijb 2019 0205 [Generate Certificate]


The metabolic syndrome is a set of abnormalities that increases the high risk in developing cardiovascular disease and type 2 diabetes. The objective of this study was to determine the prevalence of the metabolic syndrome in the population of southern Benin and associated risk factors. This was a prospective cross-sectional analytical study that ran from February 15, 2018 to May 15, 2018, including apparently healthy people aged 18 and over in four ethnic groups in southern Benin. Informed consent was obtained from each participant in the study. The metabolic syndrome has been defined according to the criteria of the International Diabetes Federation. The population consisted of 434 subjects. The average age was 40.62 ± 13.95 years old. 146 subjects or 33.64% were overweight with a female predominance (82.22% vs 17.78%, p = 0.0004). The prevalence of the metabolic syndrome was 17.1% with a female predominance (25.7% vs 6.6%, p = 0.000). Some ethnic groups are more affected than others (p = 0.031). Factors associated with the metabolic syndrome were: ethnic group, age, female sex, educational level, marital status, and physical inactivity, overweight, non-regular consumption of fruits and vegetables, and LDL hypercholesterolemia. The metabolic syndrome is a reality in the population of sub-Benin. Measures to handle the associated and predisposing factors will significantly reduce the prevalence of the metabolic syndrome and consequently, the risk of cardiovascular disease and the onset of type 2 diabetes.

| Views 73 |

| Views 73 |

Prevalence of metabolic syndrome and associated risk factors in the population of southern

Acakpo A, Fayomi B, Djrolo F, Kolanowski J, Agueh V,  Makoutode M. 2000. Prévalence et étude des facteurs déterminants de l’obésité à Cotonou. Louvain médical 119, 276–81.

Adébayo  A, Albert D. C, Ericie S, Angelo AC, Jules G, Armand W, Gabriel  A. 2015. Prevalence, associated and predisposing factors of metabolic syndrome among people living with HIV on antiretroviral treatment in Porto Novo in 2014. The Pan African medical journal 22, 296.

Alberti KG, MM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Smith SC. 2009. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation 120(16), 1640–1645.

Aleixandre A, Miguel M. 2008. Dietary fiber in the prevention and treatment of metabolic syndrome: A review. Critical Reviews in Food Science and Nutrition 48(10), 905–912.

Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Eschwège E. 2003. National Cholesterol Education Program (NCEP). Diabetes Metabolism, S(29), 526–532.

Bita Fouda A, Lemogoum D, Owona Manga J, Dissongo J, Tobbit R, Ngounou Moyo D. 2012. Epidemiology of obesity in the work milieu, Douala, Cameroon. Revue Médicale Bruxelle 33, 131–7.

Cameron AJ, Shaw JE, Zimmet PZ. 2004. The metabolic syndrome: Prevalence in worldwide populations. Endocrinology and Metabolism Clinics of North America 33(2), 351–375.

Dallongeville J, Cottel D, Arveiler D, Tauber J. P, Bingham A, Wagner A, Amouyel P. 2004. The Association of Metabolic Disorders with the Metabolic Syndrome Is Different in Men and Women. Annals of Nutrition and Metabolism 48(1), 43–50.

Després J, Couillard C, Gagnon J, Bergeron J, Leon A, Rao DC, Bouchard C. 2000. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: The health, risk factors, exercise training, and genetics (HERITAGE) family study. Arteriosclerosis, Thrombosis and Vascular Biology 20(8), 1932–1938.

Dovonou C, Gounongbe F, Hinson A, Alassani C, Attinsounon C, Tognon F, Fayomi B. 2016. Etude Des Facteurs De Risque De L’obésité Chez Le Personnel Du CHUD/Borgou à Parakou (Bénin) en 2013. European Scientific Journal, ESJ 12(15), 384.

Dugas LR, Carstens MA, Ebersole K, Schoeller DA, Durazo-Arvizu RA, Lambert EV, Luke A. 2009. Energy expenditure in young adult urban informal settlement dwellers in South Africa. European Journal of Clinical Nutrition 63(6), 805–807.

Eckel RH, Grundy SM, Zimmet PZ. 2005. The metabolic syndrome Robert. Lancet 365, 1415–28.

Ford ES. 2005. Prevalence of the Metabolic Syndrome Defined by the International Diabetes. Diabetes Care, 28(11), 2745–2749. Opgehaal van

Ford ES, Giles WH, Mokdad AH. 2004. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27(10), 2444–2449.

Ford ES, Li C, Sattar N, Glasgow B. 2008. Metabolic Syndrome and Incident Diabetes Current state of the evidence and the org/licenses/by-nc-nd/3.0/ for details. Diabetes Care 31(9).

Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. 2007. Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death. A Systematic Review and Meta-Analysis of Longitudinal Studies. Journal of the American College of Cardiology, 49(4), 403–414.

Gomina M, Alassani A, Codjo L, Dovonou A, Akpona S. 2016. Prevalence of Dyslipidemia on the Basis of Biochemistry Tests in the Parakou University Teaching Hospital (Benin). British Biotechnology Journal, 16(2), 1–8.

Grundy SM. 2006. Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds. Journal of the American College of Cardiology 47(6), 1093–1100.

Grundy SM. 2008. Metabolic syndrome pandemic. Arteriosclerosis, Thrombosis and Vascular Biology, 28(4), 629–636.

Grundy SM, Brewer HB, Cleeman JI, Smith S. C, Lenfant C. 2004. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation, 109(3), 433–438.

Hauhouot-Attoungbre ML, Yayo SE, Ake-Edjeme A, Yapi HF, Ahibo H, Monnet D. 2008. Le syndrome métabolique existe-t-il en Côte d’Ivoire ? Immuno-Analyse et Biologie Specialisee, 23(6), 375–378.

Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. 2004. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archives of Internal Medicine, 164(10), 1066–1076.

Janice BV, Hee-Soon J, Juhee C, Elisa RMM. 2007. Factors Associated With Overweight and Obesity Among Mexican Americans and Central Americans: Results From the 2001 California Health Interview Survey. Centers for Disease Control and Prevention.

Kraja AT, Rao DC, Weder AB, Cooper R, Curb JD, Hanis CL, Province MA. 2005. Two major QTLs and several others relate to factors of metabolic syndrome in the family blood pressure program. Hypertension 46(4), 751–758.

Lameira D, Lejeune S, Mourad JJ. 2008. Le syndrome métabolique : son épidémiologie et ses risques. Annales de Dermatologie et de Venereologie, 135(4), 249–253.

Lyon CJ, Law RE, Hsueh WA. 2003. Minireview: Adiposity, inflammation, and atherogenesis. Endocrinology 144(6), 2195–2200.

Mbemba F, Mabiala-Babela JR, Massamba A, Senga P. 2006. Profil alimentaire de l’écolier à Brazzaville, Congo. Archives de Pediatrie, 13(7), 1022–1028.

Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR. 2003. The metabolic syndrome: prevalence and associated risk factors findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archive International.Medical 163, 427–436.

Pessinaba S, Mbaye A, Yabéta GAD, Harouna

H, Sib AE, Kane AD, Kane A. 2013. Prevalence survey of cardiovascular risk factors in the general population in St. Louis (Senegal). Annales de Cardiologie et d’Angeiologie 62(4), 253–258.

Procopiou M, Philippe J. 2005. The metabolic syndrome and type 2 diabetes: Epidemiological figures and country specificities. Cerebrovascular Diseases 20(1), 2–8.

Pullinger CR, Aouizerat BE, Gay C, Coggins T, Movsesyan I, Davis H, Lee KA. 2010. Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults. Metabolic Syndrome and Related Disorders 8(3), 279–286.

Sawadogo A, Sanou S, Hema A, Kamboule B.  E, Kabore NF, Sore I, Sawadogo AB. 2014. Syndrome métabolique et risque cardiovasculaire  chez des patients sous antirétroviraux à l’hôpital de jour de Bobo-Dioulasso (Burkina Faso). Bulletin de la Societe de Pathologie Exotique 107(3), 151–158.

Silventoinen K, Pankow J, Jousilahti P, Hu G, Toumilehto J. 2005. Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. International Journal of Epidemiology 34(2), 327–334.

Sognigbé GB, Chabi Nicodème Worou, Avocèfohoun SA, Kohonou NA, Konfo TRC, Sina H, Noumavo AP, Dah Nouvlessounon D, Baba-Moussa L. 2019. Comparative study of the food habits of populations in southern Benin. International Journal of Current Research in Biosciences and Plant Biology 6(6), 1–8.

Tesfaye DY, Kinde S, Medhin G, Megerssa Y. C, Tadewos A, Tadesse E, Shimelis T. 2014. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 8(2), 102–107.

Wu PY, Hung CC, Liu WC, Hsieh CY, Sun HY, Lu CL, Chien KL. 2012. Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: Prevalence and associated factors. Journal of Antimicrobial Chemotherapy 67(4), 1001–1009.

Yessoufou AG, Behanzin J, Djihoumeto E,  Isstina ZA, Ahokpe M, Sezan A. 2015. Aspects  épidémiologiques du syndrome métabolique au sein de la population obèse de la Commune Ouidah au Sud-ouest du Bénin Epidemiological aspects of metabolic syndrome in the obese population of the municipality of Ouidah in southwestern Benin. 111–116. Opgehaal van.

Zannou DM, Denoeud L, Lacombe K, Amoussou-Guenou D, Bashi J, Akakpo J. 2009. Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin. Antiviral Therapy, 14(3), 371–380.

Zendjabil M, Abbou O, Chellouai Z. 2017. Association entre syndrome métabolique et hyperhomocystéinémie dans une population algérienne. Annales Pharmaceutiques Francaises, 75(1), 54–58.

Zimmet PZ, Magliano D, Matsuzawa Y, Alberti G, Shaw J. 2005. The metabolic syndrome: a global public health problem and a new definition. Journal of atherosclerosis and thrombosis 12(6), 295–300.

Basile G. Sognigbé, Nicodème Worou Chabi, Victorien T. Dougnon, Esther Duéguénon, Arnaud N. Kohonou, Véronique B.T. Tinéponanti, Lamine Baba-Moussa.
Prevalence of metabolic syndrome and associated risk factors in the population of southern.
Int. J. Biosci. 15(5), 205-217, November 2019.
Copyright © 2019
By Authors and International Network for
Natural Sciences (INNSPUB)
innspub logo
english language editing
    Publish Your Article
    Submit Your Article
Email Update